How Will the Market React to Nuvation Bio Inc (NUVB) Stock Getting a Bearish Rating

Nuvation Bio Inc (NUVB) stock has fallen 11.33% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Nuvation Bio Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on NUVB!

See Full NUVB Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With NUVB Stock Today?

Nuvation Bio Inc (NUVB) stock is higher by 5.56% while the S&P 500 has fallen -0.23% as of 3:29 PM on Tuesday, Sep 19. NUVB is higher by $0.07 from the previous closing price of $1.26 on volume of 7,738,827 shares. Over the past year the S&P 500 is higher by 13.93% while NUVB has fallen -38.71%. NUVB lost -$0.41 per share in the over the last 12 months. To screen for more stocks like Nuvation Bio Inc click here.

More About Nuvation Bio Inc

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Click Here to get the full Stock Report for Nuvation Bio Inc stock.